CONTACT US   |  (864) 397-5101

Vaccinating the world, one delivery at a time

COVAX momentum continues – but there is still much to be done.

Last month, COVAX reached an extraordinary milestone with the delivery of more than 1.5 billion doses of the COVID-19 vaccine to 145 countries and territories.

Since the start of the pandemic, we have been enabling delivery of COVID-19 vaccines to people around the world, with temperature controlled shipping solutions that keep vaccinations safe and efficacious from point of manufacture to people’s arms.

And just recently, on June 18, the US sent 302,400 pediatric doses of Pfizer COVID-19 vaccine to Mongolia – a COVAX delivery with support from USAID.

Earlier in the month, COVAX also supported the delivery of 58,500 COVID-19 vaccine doses in Mali. Thanks to MSDS, the US Embassy in Mali, COVAX, UNICEF and other partners – as well as a secure cold chain – safe and effective vaccines continue to reach populations across the globe.

COVAX vaccines being transported in Softbox by CSafe parcel shippers in June 2022.

These recent consignments are just latest in a steady stream of donations through COVAX facilities. Just before this, the US donated 23,400 COVID-19 vaccine doses that arrived safely Kiribati

COVID-19 vaccines arriving in Kiribati. Photo © UNICEFPacific/2022/Temakei

Throughout Spring we saw further COVAX donations reach destinations around the world – from Armenia to Zambia and countless others. Pictured below are our Silverpod pallet shippers containing COVID-19 vaccines as part of the UNICEF, GAVI, CEPI, WHO COVID-19 vaccine consignment in Armenia in March. 

And in April, the US Department of State announced that US had donated 529 million COVID-19 vaccine doses to over 110 countries and economies – we were proud to see our temperature control systems in the coverage of this World Immunization Week milestone, too.

These incredible efforts are testament to the hard work and collaboration shown by so many, and these deliveries will protect public health and economies. But lack of vaccine equity remains – and there is still much work to be done.

The cold chain is part of this continued focus. As we know, COVID-19 vaccines are temperature-sensitive, and can be spoiled or lose efficacy if this chain is broken – so our work continues in earnest too.

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.